psilocybin therapy COMP360 investigational
Selected indexed studies
- Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. (Neuropsychopharmacology, 2023) [PMID:37443386]
- Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. (Psychol Med, 2024) [PMID:38247730]
- Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder. (J Clin Psychiatry, 2025) [PMID:40047545]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. (2023) pubmed
- Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. (2024) pubmed
- Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder. (2025) pubmed
- Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment. (2025) pubmed
- Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions. (2025) pubmed
- Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa. (2025) pubmed
- Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds. (2025) pubmed
- Virtual reality interventions in obesity and eating disorders: a systematic review of biomarker, clinical, and behavioral outcomes. (2026) pubmed
- Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies. (2026) pubmed
- The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression. (2024) pubmed